Nucleoside Analog Antiviral [EPC]

Nucleoside Analog Antiviral [EPC] was reported 85500 times

These side effects are most commonly reported by patients taking drugs of the Nucleoside Analog Antiviral [EPC] class:

# Drug class Count
0 FATIGUE 11102
1 ANAEMIA 9059
2 NAUSEA 8861
3 RASH 5587
4 DIARRHOEA 5282
5 DRUG INEFFECTIVE 5111
6 HEADACHE 5058
7 PRURITUS 4735
8 VOMITING 4652
9 PYREXIA 4454
10 ASTHENIA 4239
11 DECREASED APPETITE 4071
12 WHITE BLOOD CELL COUNT DECREASED 4067
13 DEATH 3938
14 DYSPNOEA 3716
15 INSOMNIA 3549
16 OFF LABEL USE 3278
17 DIZZINESS 3122
18 WEIGHT DECREASED 3053
19 PLATELET COUNT DECREASED 2957
20 HAEMOGLOBIN DECREASED 2938
21 DEPRESSION 2642
22 PAIN 2590
23 MALAISE 2386
24 INFLUENZA LIKE ILLNESS 2331
25 HEPATITIS C 2251
26 NEUTROPENIA 2211
27 CHILLS 2107
28 DISEASE PROGRESSION 2066
29 THROMBOCYTOPENIA 1845
30 ABDOMINAL PAIN 1745
31 COUGH 1745
32 ANORECTAL DISCOMFORT 1660
33 ARTHRALGIA 1641
34 ALOPECIA 1637
35 PNEUMONIA 1608
36 DEHYDRATION 1519
37 DYSGEUSIA 1485
38 MYALGIA 1457
39 PANCYTOPENIA 1417
40 ANXIETY 1404
41 ASCITES 1396
42 ABDOMINAL PAIN UPPER 1328
43 LEUKOPENIA 1296
44 RASH PRURITIC 1278
45 SEPSIS 1275
46 CYTOMEGALOVIRUS INFECTION 1256
47 RED BLOOD CELL COUNT DECREASED 1219
48 DRY SKIN 1159
49 CONSTIPATION 1142
50 IRRITABILITY 1141
51 HEPATIC FAILURE 1129
52 TREATMENT FAILURE 1125
53 NEUTROPHIL COUNT DECREASED 1101
54 DRUG DOSE OMISSION 1040
55 BACK PAIN 1035
56 RENAL IMPAIRMENT 1030
57 DRUG INTERACTION 1007
58 HAEMORRHOIDS 999
59 BLOOD BILIRUBIN INCREASED 994
60 FEELING ABNORMAL 991
61 RENAL FAILURE 981
62 VISION BLURRED 978
63 HEPATOCELLULAR CARCINOMA 976
64 CHEST PAIN 972
65 CONFUSIONAL STATE 949
66 FALL 886
67 RASH GENERALISED 862
68 HEPATIC CIRRHOSIS 853
69 PAIN IN EXTREMITY 846
70 URINARY TRACT INFECTION 835
71 SYNCOPE 834
72 ANAL PRURITUS 819
73 DRY MOUTH 814
74 ACUTE KIDNEY INJURY 809
75 CONDITION AGGRAVATED 801
76 DRUG RESISTANCE 793
77 SOMNOLENCE 789
78 HYPOTENSION 755
79 OEDEMA PERIPHERAL 746
80 MEMORY IMPAIRMENT 704
81 PRODUCT USE IN UNAPPROVED INDICATION 704
82 ABDOMINAL DISCOMFORT 700
83 JAUNDICE 698
84 EPISTAXIS 686
85 MUSCLE SPASMS 686
86 INFECTION 679
87 STOMATITIS 645
88 HYPERTENSION 635
89 ABDOMINAL DISTENSION 631
90 TREMOR 621
91 DYSPEPSIA 619
92 WEIGHT INCREASED 609
93 RESPIRATORY FAILURE 607
94 LOSS OF CONSCIOUSNESS 603
95 ALANINE AMINOTRANSFERASE INCREASED 601
96 BLOOD CREATININE INCREASED 576
97 EYE PAIN 570
98 HYPERBILIRUBINAEMIA 565
99 HYPERHIDROSIS 555
100 PRURITUS GENERALISED 552
101 LETHARGY 542
102 HYPOAESTHESIA 536
103 RECTAL HAEMORRHAGE 532
104 SEPTIC SHOCK 532
105 HEPATIC ENCEPHALOPATHY 531
106 PRODUCT USE ISSUE 528
107 PROCTALGIA 527
108 OROPHARYNGEAL PAIN 524
109 BLOOD PRESSURE INCREASED 522
110 INJECTION SITE ERYTHEMA 518
111 ERYTHEMA 515
112 MULTIPLE ORGAN DYSFUNCTION SYNDROME 512
113 HAEMATEMESIS 511
114 TACHYCARDIA 504
115 SUICIDAL IDEATION 495
116 MOOD SWINGS 479
117 ASPARTATE AMINOTRANSFERASE INCREASED 459
118 DISTURBANCE IN ATTENTION 459
119 NASOPHARYNGITIS 450
120 RASH ERYTHEMATOUS 449
121 PALPITATIONS 445
122 VISUAL IMPAIRMENT 442
123 CYTOMEGALOVIRUS VIRAEMIA 439
124 VIRAL LOAD INCREASED 431
125 GENERAL PHYSICAL HEALTH DETERIORATION 427
126 BLISTER 415
127 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 414
128 NEUROPATHY PERIPHERAL 413
129 HAEMATOCHEZIA 410
130 ANGER 409
131 CYTOMEGALOVIRUS INFECTION REACTIVATION 408
132 DEPRESSED MOOD 404
133 GASTROINTESTINAL HAEMORRHAGE 402
134 TINNITUS 402
135 BLOOD GLUCOSE INCREASED 401
136 PLEURAL EFFUSION 398
137 GAIT DISTURBANCE 397
138 PARAESTHESIA 396
139 INFLUENZA 389
140 RASH PAPULAR 387
141 RENAL FAILURE ACUTE 381
142 BLOOD COUNT ABNORMAL 379
143 HAEMATURIA 374
144 GENERALISED OEDEMA 370
145 COMA 367
146 PHOTOPHOBIA 367
147 ENCEPHALOPATHY 364
148 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 364
149 PATHOGEN RESISTANCE 360
150 HAEMOLYTIC ANAEMIA 357
151 AMNESIA 356
152 CONTUSION 355
153 LIVER DISORDER 354
154 BONE PAIN 353
155 MALIGNANT NEOPLASM PROGRESSION 351
156 DYSPNOEA EXERTIONAL 346
157 BLINDNESS 345
158 BLOOD POTASSIUM DECREASED 345
159 HAEMORRHAGE 341
160 MIGRAINE 340
161 PANCREATITIS 339
162 URTICARIA 338
163 DYSPHAGIA 334
164 GASTROINTESTINAL DISORDER 331
165 FEBRILE NEUTROPENIA 328
166 CHEST DISCOMFORT 327
167 HYPOKALAEMIA 326
168 TRANSPLANT REJECTION 320
169 INTENTIONAL PRODUCT USE ISSUE 317
170 CARDIO-RESPIRATORY ARREST 316
171 NO ADVERSE EVENT 315
172 SWELLING FACE 315
173 MENTAL DISORDER 314
174 PRESYNCOPE 312
175 ALTERED STATE OF CONSCIOUSNESS 311
176 CYTOPENIA 311
177 HEPATIC FUNCTION ABNORMAL 311
178 INJECTION SITE REACTION 311
179 MUSCULAR WEAKNESS 311
180 SKIN EXFOLIATION 311
181 NO THERAPEUTIC RESPONSE 310
182 SLEEP DISORDER 308
183 HEART RATE INCREASED 307
184 SKIN DISORDER 307
185 OVERDOSE 304
186 HALLUCINATION 301
187 GASTROOESOPHAGEAL REFLUX DISEASE 300
188 INCORRECT DOSE ADMINISTERED 300
189 HYPONATRAEMIA 298
190 MYOCARDIAL INFARCTION 296
191 AGITATION 295
192 CHROMATURIA 295
193 HAEMATOCRIT DECREASED 293
194 HYPERSENSITIVITY 292
195 INJECTION SITE RASH 291
196 CELLULITIS 289
197 PERIPHERAL SWELLING 287
198 DIABETES MELLITUS 286
199 CONVULSION 282
200 NEPHROPATHY TOXIC 282
201 VERTIGO 282
202 HEPATIC ENZYME INCREASED 281
203 BRONCHITIS 279
204 BONE MARROW FAILURE 277
205 OEDEMA 275
206 CEREBROVASCULAR ACCIDENT 273
207 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 273
208 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 273
209 DIPLOPIA 272
210 HAEMORRHAGIC STROKE 272
211 DRUG INTOLERANCE 270
212 OCULAR DISCOMFORT 269
213 THROMBOSIS 268
214 TRANSFUSION 268
215 ATRIAL FIBRILLATION 267
216 MULTI-ORGAN FAILURE 267
217 TOXICITY TO VARIOUS AGENTS 265
218 EPSTEIN-BARR VIRUS INFECTION 263
219 MYELOSUPPRESSION 263
220 HEAD DISCOMFORT 262
221 INTERSTITIAL LUNG DISEASE 262
222 CARDIAC ARREST 261
223 CRYING 261
224 LYMPHADENOPATHY 261
225 BALANCE DISORDER 260
226 FEELING HOT 259
227 RENAL DISORDER 259
228 THERAPY NON-RESPONDER 257
229 DYSURIA 253
230 MUSCULOSKELETAL PAIN 252
231 SINUSITIS 251
232 DEEP VEIN THROMBOSIS 247
233 STAPHYLOCOCCAL INFECTION 246
234 CARDIAC FAILURE 245
235 FEELING COLD 243
236 VIROLOGIC FAILURE 242
237 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 237
238 INJECTION SITE BRUISING 237
239 RASH MACULAR 237
240 HYPERSOMNIA 235
241 PULMONARY EMBOLISM 235
242 RESPIRATORY DISTRESS 235
243 AMAUROSIS FUGAX 232
244 DISEASE RECURRENCE 232
245 GRAFT VERSUS HOST DISEASE 232
246 ORAL PAIN 232
247 FLATULENCE 229
248 ADVERSE EVENT 226
249 RETINOPATHY 226
250 EMOTIONAL DISORDER 223
251 PRODUCTIVE COUGH 223
252 DISORIENTATION 222
253 AGGRESSION 221
254 COLITIS 220
255 THROMBOTIC MICROANGIOPATHY 220
256 DYSPHONIA 217
257 HYPOTHYROIDISM 217
258 INTESTINAL OBSTRUCTION 217
259 POLLAKIURIA 217
260 CHOLELITHIASIS 216
261 TREATMENT NONCOMPLIANCE 216
262 BURNING SENSATION 214
263 HYPERURICAEMIA 214
264 URINARY TRACT DISORDER 214
265 CYSTITIS HAEMORRHAGIC 213
266 NERVOUSNESS 212
267 HOSPITALISATION 211
268 FAECES DISCOLOURED 210
269 LYMPHOPENIA 210
270 CYTOMEGALOVIRUS CHORIORETINITIS 209
271 MOOD ALTERED 209
272 LUNG DISORDER 205
273 SWELLING 203
274 SKIN ULCER 202
275 CYTOMEGALOVIRUS COLITIS 201
276 MOUTH ULCERATION 201
277 HERPES ZOSTER 200
278 HYPOPHAGIA 199
279 BLOOD PRESSURE DECREASED 197
280 JOINT SWELLING 197
281 PSYCHOTIC DISORDER 197
282 BK VIRUS INFECTION 196
283 HAEMOPTYSIS 196
284 PANIC ATTACK 196
285 HEPATITIS E 193
286 HYPERGLYCAEMIA 193
287 HEPATIC CANCER 192
288 PNEUMONIA CYTOMEGALOVIRAL 192
289 TRANSAMINASES INCREASED 191
290 VIRAL INFECTION 191
291 PALLOR 189
292 PSORIASIS 189
293 ACUTE RESPIRATORY DISTRESS SYNDROME 188
294 ORAL CANDIDIASIS 188
295 PHOTOSENSITIVITY REACTION 188
296 RHINORRHOEA 187
297 EYE IRRITATION 186
298 LIVER TRANSPLANT 185
299 DRY EYE 184
300 INJECTION SITE PAIN 184
301 SEIZURE 184
302 SKIN LESION 184
303 WHITE BLOOD CELL COUNT INCREASED 184
304 GENOTYPE DRUG RESISTANCE TEST POSITIVE 183
305 RASH MACULO-PAPULAR 183
306 ECZEMA 182
307 VISUAL ACUITY REDUCED 182
308 FULL BLOOD COUNT DECREASED 181
309 THIRST 181
310 FUNGAL INFECTION 180
311 CANDIDA INFECTION 179
312 FLUID RETENTION 177
313 DRUG ERUPTION 176
314 HYPERKALAEMIA 176
315 PERITONITIS BACTERIAL 175
316 CEREBRAL HAEMORRHAGE 174
317 GASTRITIS 174
318 LOCAL SWELLING 173
319 NIGHT SWEATS 173
320 PNEUMOCYSTIS JIROVECII PNEUMONIA 173
321 PANCREATITIS ACUTE 172
322 BODY TEMPERATURE INCREASED 171
323 ENCEPHALITIS CYTOMEGALOVIRUS 171
324 PRODUCT QUALITY ISSUE 170
325 GASTRIC ULCER 169
326 NECK PAIN 169
327 SKIN DISCOLOURATION 169
328 UNEVALUABLE EVENT 169
329 SPLENOMEGALY 168
330 VARICES OESOPHAGEAL 168
331 MEDICATION ERROR 167
332 OESOPHAGEAL VARICES HAEMORRHAGE 167
333 BLOOD UREA INCREASED 166
334 GLOSSODYNIA 166
335 UPPER RESPIRATORY TRACT INFECTION 166
336 HAEMOLYSIS 163
337 ASTHMA 160
338 NEPHROLITHIASIS 160
339 COVID-19 159
340 ORAL HERPES 159
341 MENTAL STATUS CHANGES 158
342 PULMONARY OEDEMA 157
343 HAEMORRHOIDAL HAEMORRHAGE 156
344 INJECTION SITE PRURITUS 156
345 BACTERIAL INFECTION 155
346 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 154
347 THYROID DISORDER 153
348 ADVERSE DRUG REACTION 152
349 EYE SWELLING 152
350 RETINAL HAEMORRHAGE 152
351 BRONCHOPULMONARY ASPERGILLOSIS 151
352 CHRONIC KIDNEY DISEASE 151
353 HEPATITIS 151
354 SUICIDE ATTEMPT 151
355 DYSARTHRIA 150
356 OCULAR HYPERAEMIA 150
357 ASPERGILLUS INFECTION 149
358 HEPATIC PAIN 149
359 DISSEMINATED INTRAVASCULAR COAGULATION 148
360 THERAPEUTIC RESPONSE DECREASED 148
361 UNDERDOSE 148
362 APLASTIC ANAEMIA 147
363 RETCHING 147
364 VIRAL MUTATION IDENTIFIED 147
365 ACUTE GRAFT VERSUS HOST DISEASE 146
366 DRUG-INDUCED LIVER INJURY 146
367 END STAGE RENAL DISEASE 146
368 MUCOSAL INFLAMMATION 146
369 PNEUMONITIS 146
370 ANOREXIA 145
371 BLOOD URIC ACID INCREASED 145
372 ARRHYTHMIA 144
373 NASAL CONGESTION 144
374 HYPOXIA 143
375 LABORATORY TEST ABNORMAL 143
376 LIVER FUNCTION TEST ABNORMAL 143
377 AMMONIA INCREASED 142
378 RHABDOMYOLYSIS 141
379 METABOLIC ACIDOSIS 140
380 BACTERAEMIA 139
381 HAEMATOTOXICITY 138
382 LUNG INFECTION 138
383 HEPATITIS B REACTIVATION 137
384 HYPERTHYROIDISM 137
385 STRESS 137
386 ACUTE RESPIRATORY FAILURE 136
387 HAEMORRHAGE INTRACRANIAL 136
388 RESPIRATORY DISORDER 136
389 SKIN BURNING SENSATION 136
390 AGRANULOCYTOSIS 135
391 COGNITIVE DISORDER 135
392 DELIRIUM 133
393 DERMATITIS 133
394 RESTLESSNESS 133
395 GINGIVAL BLEEDING 131
396 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 130
397 HOT FLUSH 130
398 MELAENA 130
399 PRODUCT DOSE OMISSION IN ERROR 130
400 CARDIAC DISORDER 129
401 PARANOIA 129
402 BLOOD GLUCOSE DECREASED 128
403 CHOLESTASIS 128
404 LOWER RESPIRATORY TRACT INFECTION 128
405 SPEECH DISORDER 128
406 BLOOD SODIUM DECREASED 127
407 LACTIC ACIDOSIS 127
408 ANORECTAL DISORDER 126
409 DRUG ADMINISTRATION ERROR 126
410 STEVENS-JOHNSON SYNDROME 126
411 DRUG HYPERSENSITIVITY 125
412 UPPER GASTROINTESTINAL HAEMORRHAGE 125
413 MUSCULOSKELETAL STIFFNESS 124
414 POOR QUALITY SLEEP 124
415 CYSTITIS 122
416 HEPATITIS CHOLESTATIC 122
417 PERICARDIAL EFFUSION 122
418 BLOOD DISORDER 121
419 C-REACTIVE PROTEIN INCREASED 121
420 ENTEROCOCCAL INFECTION 121
421 FACE OEDEMA 121
422 INJECTION SITE HAEMORRHAGE 121
423 PROTEINURIA 121
424 APLASIA PURE RED CELL 120
425 KLEBSIELLA INFECTION 120
426 BRADYCARDIA 119
427 GAMMA-GLUTAMYLTRANSFERASE INCREASED 119
428 SWOLLEN TONGUE 119
429 ABASIA 118
430 FREQUENT BOWEL MOVEMENTS 118
431 GASTROENTERITIS 118
432 LIVER TRANSPLANT REJECTION 118
433 PSEUDOMONAS INFECTION 118
434 CARDIAC FAILURE CONGESTIVE 117
435 ILLNESS 117
436 MALNUTRITION 117
437 BILIRUBIN CONJUGATED INCREASED 116
438 INCORRECT DRUG ADMINISTRATION DURATION 115
439 LYMPHOCYTE COUNT DECREASED 115
440 ACCIDENTAL OVERDOSE 114
441 AUTOIMMUNE HEPATITIS 114
442 BLOOD ALBUMIN DECREASED 114
443 EAR PAIN 114
444 MENTAL IMPAIRMENT 114
445 TRANSIENT ISCHAEMIC ATTACK 114
446 CATARACT 113
447 ORAL MUCOSAL BLISTERING 113
448 RETINAL DETACHMENT 113
449 CLOSTRIDIUM DIFFICILE COLITIS 112
450 HEPATOTOXICITY 112
451 BLOOD ALKALINE PHOSPHATASE INCREASED 111
452 ERYTHEMA MULTIFORME 111
453 ARTHRITIS 110
454 COLORECTAL CANCER METASTATIC 110
455 ABNORMAL BEHAVIOUR 109
456 RESPIRATORY TRACT INFECTION 109
457 ACUTE HEPATIC FAILURE 108
458 ADENOVIRUS INFECTION 108
459 EAR INFECTION 108
460 HYPOGLYCAEMIA 108
461 SMOOTH MUSCLE CELL NEOPLASM 108
462 AGEUSIA 107
463 EPSTEIN-BARR VIRAEMIA 106
464 THERAPY INTERRUPTED 106
465 BLOOD TEST ABNORMAL 105
466 CYTOMEGALOVIRUS TEST POSITIVE 105
467 SHOCK 105
468 SKIN REACTION 105
469 BLOOD URINE PRESENT 104
470 EATING DISORDER 104
471 GOUT 104
472 ROAD TRAFFIC ACCIDENT 104
473 VAGINAL HAEMORRHAGE 104
474 HEPATITIS C RNA INCREASED 103
475 HYPOMAGNESAEMIA 103
476 PAROSMIA 103
477 PRODUCT DOSE OMISSION ISSUE 103
478 DEAFNESS 102
479 EMOTIONAL DISTRESS 102
480 INTERNATIONAL NORMALISED RATIO INCREASED 102
481 PORTAL VEIN THROMBOSIS 102
482 TOXIC SKIN ERUPTION 102
483 COLITIS ULCERATIVE 101
484 PNEUMONIA BACTERIAL 101
485 ABDOMINAL PAIN LOWER 100
486 WHEEZING 99
487 DEPRESSED LEVEL OF CONSCIOUSNESS 98
488 RETINAL EXUDATES 98
489 THERAPY CESSATION 98
490 DIARRHOEA HAEMORRHAGIC 97
491 EPILEPSY 97
492 EYE DISORDER 97
493 HEPATIC FIBROSIS 97
494 LIVER INJURY 97
495 ANAL HAEMORRHAGE 96
496 ELECTROLYTE IMBALANCE 96
497 REMISSION NOT ACHIEVED 96
498 SKIN IRRITATION 96
499 STAPHYLOCOCCAL SEPSIS 96
500 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 95
501 GASTRIC DISORDER 95
502 HEPATOMEGALY 95
503 HYPOALBUMINAEMIA 95
504 ILL-DEFINED DISORDER 95
505 PORTAL HYPERTENSION 95
506 TOOTHACHE 95
507 COAGULOPATHY 94
508 MASS 93
509 OXYGEN SATURATION DECREASED 93
510 ANGINA PECTORIS 92
511 EYE PRURITUS 92
512 KIDNEY TRANSPLANT REJECTION 92
513 LYMPHOMA 92
514 NERVOUS SYSTEM DISORDER 92
515 CHOLANGITIS 91
516 THROAT IRRITATION 91
517 HYPOGAMMAGLOBULINAEMIA 90
518 MATERNAL EXPOSURE DURING PREGNANCY 90
519 VASCULITIS 90
520 ABORTION SPONTANEOUS 89
521 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 89
522 HEAD INJURY 89
523 MOBILITY DECREASED 89
524 THINKING ABNORMAL 89
525 BLOOD IRON DECREASED 88
526 BLOOD TRIGLYCERIDES INCREASED 88
527 IMMUNE SYSTEM DISORDER 88
528 IMPAIRED WORK ABILITY 88
529 KIDNEY INFECTION 88
530 ACUTE MYOCARDIAL INFARCTION 87
531 BLOOD LACTATE DEHYDROGENASE INCREASED 87
532 DRUG LEVEL INCREASED 87
533 EXPOSURE DURING PREGNANCY 87
534 HEPATORENAL SYNDROME 87
535 OCULAR ICTERUS 87
536 URINARY RETENTION 86
537 BLOOD CREATINE PHOSPHOKINASE INCREASED 85
538 NEPHROTIC SYNDROME 85
539 PERITONITIS 85
540 PREGNANCY 85
541 TUBULOINTERSTITIAL NEPHRITIS 85
542 AFFECT LABILITY 84
543 FLUSHING 84
544 HEPATIC NEOPLASM MALIGNANT 84
545 LACRIMATION INCREASED 84
546 MUSCLE ATROPHY 84
547 PNEUMOTHORAX 84
548 SLUGGISHNESS 84
549 ABNORMAL DREAMS 83
550 ENCEPHALITIS 83
551 EOSINOPHILIA 83
552 GASTROENTERITIS VIRAL 83
553 GRAFT VERSUS HOST DISEASE IN SKIN 83
554 FEELING OF BODY TEMPERATURE CHANGE 82
555 PAIN OF SKIN 82
556 SMALL INTESTINAL OBSTRUCTION 82
557 THERAPY PARTIAL RESPONDER 82
558 CLOSTRIDIUM DIFFICILE INFECTION 81
559 DRY THROAT 81
560 PAINFUL DEFAECATION 81
561 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 81
562 CHOLECYSTITIS 80
563 ESCHERICHIA INFECTION 80
564 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 80
565 MANIA 80
566 SKIN FISSURES 80
567 CHRONIC GRAFT VERSUS HOST DISEASE 79
568 FEEDING DISORDER 79
569 GASTROINTESTINAL INFECTION 79
570 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 79
571 TUBERCULOSIS 79
572 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 78
573 DRUG DEPENDENCE 78
574 FOETAL EXPOSURE DURING PREGNANCY 78
575 TOXIC EPIDERMAL NECROLYSIS 78
576 DIABETIC KETOACIDOSIS 77
577 DISCOMFORT 77
578 SARCOIDOSIS 77
579 CRYOGLOBULINAEMIA 76
580 TRANSPLANT FAILURE 76
581 APHASIA 75
582 DYSKINESIA 75
583 HYDRONEPHROSIS 75
584 IMPAIRED HEALING 75
585 LEUKOCYTOSIS 75
586 LIP SWELLING 75
587 PULMONARY FIBROSIS 75
588 URINARY INCONTINENCE 75
589 APHAGIA 74
590 COLON CANCER 74
591 HEPATIC STEATOSIS 74
592 PYELONEPHRITIS 74
593 GINGIVAL PAIN 73
594 HOMICIDAL IDEATION 73
595 INFLAMMATION 73
596 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 73
597 PERICARDITIS 73
598 PNEUMONIA ASPIRATION 73
599 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 73
600 ABSCESS 72
601 HYPERAESTHESIA 72
602 IMMUNODEFICIENCY 72
603 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 72
604 KAPOSI^S SARCOMA 72
605 YELLOW SKIN 72
606 BRAIN OEDEMA 71
607 DIZZINESS POSTURAL 71
608 PULMONARY HAEMORRHAGE 71
609 ACTIVITIES OF DAILY LIVING IMPAIRED 70
610 CACHEXIA 70
611 CONJUNCTIVITIS 70
612 FLANK PAIN 70
613 GLOMERULAR FILTRATION RATE DECREASED 70
614 NEUTROPHIL COUNT INCREASED 70
615 RENAL PAIN 70
616 SKIN INFECTION 70
617 ACNE 69
618 MUSCULOSKELETAL CHEST PAIN 69
619 NIGHTMARE 69
620 PORPHYRIA NON-ACUTE 69
621 SERUM FERRITIN INCREASED 69
622 STAPHYLOCOCCAL BACTERAEMIA 69
623 CHEILITIS 68
624 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 68
625 EXTRA DOSE ADMINISTERED 68
626 HEPATIC NEOPLASM 68
627 HYPOCALCAEMIA 68
628 RASH VESICULAR 68
629 SENSORY DISTURBANCE 68
630 BLOOD CALCIUM DECREASED 67
631 COLD SWEAT 67
632 HAEMATOMA 67
633 ILEUS 67
634 INJECTION SITE SWELLING 67
635 LUNG INFILTRATION 67
636 POLYNEUROPATHY 67
637 RENAL TUBULAR NECROSIS 67
638 SURGERY 67
639 THERAPEUTIC RESPONSE UNEXPECTED 67
640 UVEITIS 67
641 APATHY 66
642 ERUCTATION 66
643 IRON DEFICIENCY ANAEMIA 66
644 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 65
645 HERPES SIMPLEX 65
646 HERPES VIRUS INFECTION 65
647 METASTASES TO LIVER 65
648 MUCORMYCOSIS 65
649 NEOPLASM MALIGNANT 65
650 NEUROTOXICITY 65
651 ORAL DISCOMFORT 65
652 PHARYNGITIS 65
653 RESTLESS LEGS SYNDROME 65
654 TONGUE DISORDER 65
655 APPENDICITIS 64
656 APPETITE DISORDER 64
657 ATELECTASIS 64
658 CIRCULATORY COLLAPSE 64
659 FURUNCLE 64
660 MENORRHAGIA 64
661 POST PROCEDURAL COMPLICATION 64
662 PULMONARY HYPERTENSION 64
663 PULMONARY TUBERCULOSIS 64
664 BLOOD POTASSIUM INCREASED 63
665 DRUG EFFECT INCOMPLETE 63
666 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 63
667 HALLUCINATION, VISUAL 63
668 PAIN IN JAW 63
669 PERIPHERAL COLDNESS 63
670 TACHYPNOEA 63
671 VIITH NERVE PARALYSIS 63
672 PROCEDURAL COMPLICATION 62
673 PULMONARY CONGESTION 62
674 UNRESPONSIVE TO STIMULI 62
675 BACTERIAL SEPSIS 61
676 BEDRIDDEN 61
677 CHOLECYSTITIS ACUTE 61
678 DRUG ABUSE 61
679 HEMIPARESIS 61
680 IMMUNOSUPPRESSION 61
681 VENOOCCLUSIVE LIVER DISEASE 61
682 ANGIOEDEMA 60
683 AUTOIMMUNE THYROIDITIS 60
684 DYSSTASIA 60
685 INJECTION SITE MASS 60
686 SHOCK HAEMORRHAGIC 60
687 TOOTH LOSS 60
688 CARDIOMYOPATHY 59
689 HALLUCINATION, AUDITORY 59
690 HEART RATE DECREASED 59
691 MOUTH HAEMORRHAGE 59
692 RHEUMATOID ARTHRITIS 59
693 CHAPPED LIPS 58
694 HEPATITIS C RNA POSITIVE 58
695 INTESTINAL PERFORATION 58
696 PULMONARY MASS 58
697 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 58
698 UROSEPSIS 58
699 VIRAL HAEMORRHAGIC CYSTITIS 58
700 FIBROSIS 57
701 MOVEMENT DISORDER 57
702 NEURALGIA 57
703 TOOTH ABSCESS 57
704 ULCER 57
705 CANDIDIASIS 56
706 CHRONIC HEPATITIS C 56
707 DIALYSIS 56
708 FORMICATION 56
709 HAEMOGLOBIN ABNORMAL 56
710 INJURY 56
711 METASTASES TO LUNG 56
712 PULMONARY ARTERIAL HYPERTENSION 56
713 TYPE 2 DIABETES MELLITUS 56
714 ACCIDENTAL EXPOSURE TO PRODUCT 55
715 BLOOD THYROID STIMULATING HORMONE INCREASED 55
716 CARCINOEMBRYONIC ANTIGEN INCREASED 55
717 DEVICE RELATED INFECTION 55
718 ERECTILE DYSFUNCTION 55
719 ESCHERICHIA SEPSIS 55
720 EYE HAEMORRHAGE 55
721 HAIR TEXTURE ABNORMAL 55
722 INTENTIONAL DOSE OMISSION 55
723 LACERATION 55
724 MENINGITIS 55
725 MUSCLE TWITCHING 55
726 SINUS DISORDER 55
727 TOOTH EXTRACTION 55
728 CEREBRAL INFARCTION 54
729 EMPHYSEMA 54
730 PERSONALITY CHANGE 54
731 PLEURISY 54
732 TYPE 1 DIABETES MELLITUS 54
733 VIRAEMIA 54
734 ANURIA 53
735 ATAXIA 53
736 BLOOD MAGNESIUM DECREASED 53
737 CYTOMEGALOVIRUS ENTEROCOLITIS 53
738 DIABETES MELLITUS INADEQUATE CONTROL 53
739 LIP DRY 53
740 LOCALISED INFECTION 53
741 NASAL DRYNESS 53
742 NEOPLASM PROGRESSION 53
743 OLIGURIA 53
744 PRODUCT DOSE OMISSION 53
745 PSYCHIATRIC SYMPTOM 53
746 TOOTH DISORDER 53
747 COMPLETED SUICIDE 52
748 ENDOCARDITIS 52
749 ENTEROCOLITIS 52
750 INCREASED APPETITE 52
751 POLYURIA 52
752 SUBARACHNOID HAEMORRHAGE 52
753 DIFFUSE LARGE B-CELL LYMPHOMA 51
754 HYPOVOLAEMIA 51
755 OSTEOPOROSIS 51
756 PARVOVIRUS B19 INFECTION 51
757 PURPURA 51
758 TONGUE DISCOLOURATION 51
759 TONGUE ULCERATION 51
760 BASAL CELL CARCINOMA 50
761 DIVERTICULITIS 50
762 FEAR 50
763 FIBROMYALGIA 50
764 HEPATIC LESION 50
765 LIPASE INCREASED 50
766 MUSCLE TIGHTNESS 50
767 ORAL DISORDER 50
768 PRODUCT PACKAGING QUANTITY ISSUE 50
769 TRANSPLANT DYSFUNCTION 50
770 URINE OUTPUT DECREASED 50
771 WHITE BLOOD CELL COUNT ABNORMAL 50
772 CARDIOVASCULAR DISORDER 49
773 DENTAL CARIES 49
774 ENTERITIS 49
775 EYELID OEDEMA 49
776 FACIAL PALSY 49
777 GLAUCOMA 49
778 HAEMODIALYSIS 49
779 HYPERAMMONAEMIA 49
780 ORAL INTAKE REDUCED 49
781 PETECHIAE 49
782 RENAL INJURY 49
783 SCAB 49
784 TASTE DISORDER 49
785 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 48
786 BRAIN HERNIATION 48
787 HEPATITIS C VIRUS TEST POSITIVE 48
788 HYPERTRANSAMINASAEMIA 48
789 JOINT STIFFNESS 48
790 SCIATICA 48
791 SINUS TACHYCARDIA 48
792 SQUAMOUS CELL CARCINOMA OF SKIN 48
793 VITREOUS FLOATERS 48
794 COMPLICATIONS OF TRANSPLANTED KIDNEY 47
795 DECREASED INTEREST 47
796 DEPRESSIVE SYMPTOM 47
797 GRANULOCYTOPENIA 47
798 INCREASED TENDENCY TO BRUISE 47
799 LIVER FUNCTION TEST INCREASED 47
800 NOCTURIA 47
801 ORTHOSTATIC HYPOTENSION 47
802 PHARYNGEAL OEDEMA 47
803 PROTEIN URINE PRESENT 47
804 SCAR 47
805 ANHEDONIA 46
806 APHTHOUS STOMATITIS 46
807 ELECTROCARDIOGRAM QT PROLONGED 46
808 EXPOSURE VIA DIRECT CONTACT 46
809 FAECES PALE 46
810 FEELING JITTERY 46
811 GUILLAIN-BARRE SYNDROME 46
812 HAEMODYNAMIC INSTABILITY 46
813 HISTIOCYTOSIS HAEMATOPHAGIC 46
814 HYPERTENSIVE CRISIS 46
815 OSTEOARTHRITIS 46
816 SINUS CONGESTION 46
817 SUBDURAL HAEMATOMA 46
818 BLEEDING VARICOSE VEIN 45
819 BLOOD CHOLESTEROL INCREASED 45
820 CYTOMEGALOVIRUS SYNDROME 45
821 DERMATITIS ALLERGIC 45
822 FACIAL PARALYSIS 45
823 HYPERLIPIDAEMIA 45
824 IMMUNE THROMBOCYTOPENIA 45
825 LUNG NEOPLASM MALIGNANT 45
826 NEOPLASM 45
827 ORGANISING PNEUMONIA 45
828 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 45
829 RENAL TUBULAR DISORDER 45
830 SINUS HEADACHE 45
831 SUPRAVENTRICULAR TACHYCARDIA 45
832 TOOTH INFECTION 45
833 ARTHROPATHY 44
834 CYTOMEGALOVIRUS GASTROINTESTINAL INFECTION 44
835 ESCHERICHIA URINARY TRACT INFECTION 44
836 FLUID OVERLOAD 44
837 GALLBLADDER DISORDER 44
838 GRAND MAL CONVULSION 44
839 HEPATIC CANCER RECURRENT 44
840 HEPATITIS B 44
841 HERNIA 44
842 IRRITABLE BOWEL SYNDROME 44
843 LIBIDO DECREASED 44
844 MUSCULOSKELETAL DISORDER 44
845 PNEUMOCYSTIS JIROVECII INFECTION 44
846 PROCEDURAL PAIN 44
847 PSYCHOMOTOR HYPERACTIVITY 44
848 RASH PUSTULAR 44
849 RESPIRATORY TRACT CONGESTION 44
850 RIB FRACTURE 44
851 SUNBURN 44
852 BLOOD GLUCOSE FLUCTUATION 43
853 CORONARY ARTERY DISEASE 43
854 DRUG EFFECT DECREASED 43
855 DRUG WITHDRAWAL SYNDROME 43
856 FOLLICULITIS 43
857 HUMAN HERPESVIRUS 6 INFECTION 43
858 INTERVERTEBRAL DISC PROTRUSION 43
859 RESPIRATORY SYNCYTIAL VIRUS INFECTION 43
860 SUDDEN DEATH 43
861 AFFECTIVE DISORDER 42
862 ANAPHYLACTIC REACTION 42
863 AUTOIMMUNE DISORDER 42
864 BLINDNESS UNILATERAL 42
865 HEART RATE IRREGULAR 42
866 HYPOPHOSPHATAEMIA 42
867 INCISION SITE PAIN 42
868 INCOHERENT 42
869 INCREASED UPPER AIRWAY SECRETION 42
870 LUNG ABSCESS 42
871 NECROTISING RETINITIS 42
872 OESOPHAGEAL CANDIDIASIS 42
873 PRODUCT DISTRIBUTION ISSUE 42
874 RESPIRATORY ARREST 42
875 THYROID FUNCTION TEST ABNORMAL 42
876 APHONIA 41
877 ASPIRATION 41
878 BIPOLAR DISORDER 41
879 CYTOMEGALOVIRUS OESOPHAGITIS 41
880 FLUID INTAKE REDUCED 41
881 HUMAN HERPESVIRUS 8 INFECTION 41
882 ISCHAEMIC STROKE 41
883 LIMB INJURY 41
884 MACULAR OEDEMA 41
885 ODYNOPHAGIA 41
886 OSTEOMYELITIS 41
887 ACUTE PSYCHOSIS 40
888 ANAL FISSURE 40
889 ESCHERICHIA BACTERAEMIA 40
890 HYPERCALCAEMIA 40
891 INFECTION REACTIVATION 40
892 PROTHROMBIN TIME PROLONGED 40
893 VARICELLA ZOSTER VIRUS INFECTION 40
894 WOUND 40
895 CHOLECYSTECTOMY 39
896 COORDINATION ABNORMAL 39
897 CYTOKINE RELEASE SYNDROME 39
898 CYTOMEGALOVIRUS GASTRITIS 39
899 DEAFNESS NEUROSENSORY 39
900 DERMATITIS EXFOLIATIVE 39
901 FULL BLOOD COUNT ABNORMAL 39
902 INJECTION SITE HAEMATOMA 39
903 PREMATURE BABY 39
904 SKIN HAEMORRHAGE 39
905 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 39
906 TEARFULNESS 39
907 THROAT TIGHTNESS 39
908 ADVERSE REACTION 38
909 BLOOD GLUCOSE ABNORMAL 38
910 COVID-19 PNEUMONIA 38
911 HYPERTRIGLYCERIDAEMIA 38
912 MUSCULOSKELETAL DISCOMFORT 38
913 MYOCARDITIS 38
914 PLATELET COUNT INCREASED 38
915 POLYOMAVIRUS-ASSOCIATED NEPHROPATHY 38
916 SYSTEMIC LUPUS ERYTHEMATOSUS 38
917 THERAPEUTIC PRODUCT INEFFECTIVE 38
918 TOOTH FRACTURE 38
919 VOGT-KOYANAGI-HARADA SYNDROME 38
920 WRONG TECHNIQUE IN DRUG USAGE PROCESS 38
921 ABNORMAL FAECES 37
922 ASPERGILLOSIS 37
923 BRONCHOPNEUMONIA 37
924 CANCER PAIN 37
925 CD4 LYMPHOCYTES DECREASED 37
926 DERMATITIS BULLOUS 37
927 DRUG EXPOSURE DURING PREGNANCY 37
928 GENERAL PHYSICAL CONDITION ABNORMAL 37
929 GENERALISED TONIC-CLONIC SEIZURE 37
930 HEPATOCELLULAR INJURY 37
931 HYPERLACTACIDAEMIA 37
932 LIVER ABSCESS 37
933 LYMPHOPROLIFERATIVE DISORDER 37
934 MULTIPLE-DRUG RESISTANCE 37
935 NEUTROPENIC SEPSIS 37
936 PAPULE 37
937 SNEEZING 37
938 STOMA SITE HAEMORRHAGE 37
939 SUBCUTANEOUS ABSCESS 37
940 ACIDOSIS 36
941 ALCOHOLISM 36
942 BONE MARROW TOXICITY 36
943 COLITIS ISCHAEMIC 36
944 CORONARY ARTERY OCCLUSION 36
945 DECREASED IMMUNE RESPONSIVENESS 36
946 ERYSIPELAS 36
947 FOOT FRACTURE 36
948 GAIT INABILITY 36
949 GLOMERULOSCLEROSIS 36
950 INTENTIONAL PRODUCT MISUSE 36
951 MAJOR DEPRESSION 36
952 OSTEONECROSIS 36
953 SCEDOSPORIUM INFECTION 36
954 TEMPERATURE INTOLERANCE 36
955 WITHDRAWAL SYNDROME 36
956 ABDOMINAL TENDERNESS 35
957 ACINETOBACTER INFECTION 35
958 ANAL ABSCESS 35
959 CARDIOMEGALY 35
960 FUNGAL SEPSIS 35
961 GASTRIC HAEMORRHAGE 35
962 GASTROINTESTINAL TOXICITY 35
963 HEPATOSPLENOMEGALY 35
964 HYPOAESTHESIA ORAL 35
965 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 35
966 INTESTINAL HAEMORRHAGE 35
967 NEUROLOGICAL DECOMPENSATION 35
968 OPTIC ISCHAEMIC NEUROPATHY 35
969 PNEUMONIA VIRAL 35
970 RETINITIS 35
971 SKIN TOXICITY 35
972 THYROIDITIS 35
973 BILE DUCT OBSTRUCTION 34
974 BLOOD IRON INCREASED 34
975 BREAST CANCER 34
976 CARDIOGENIC SHOCK 34
977 DELUSION 34
978 DRUG TOXICITY 34
979 EAR DISCOMFORT 34
980 FACIAL PAIN 34
981 GLOMERULONEPHRITIS 34
982 HIP FRACTURE 34
983 LARYNGITIS 34
984 MYOCARDIAL ISCHAEMIA 34
985 MYOSITIS 34
986 PROCTITIS 34
987 PULMONARY THROMBOSIS 34
988 SCRATCH 34
989 STENOTROPHOMONAS INFECTION 34
990 STENT PLACEMENT 34
991 WOUND INFECTION 34
992 ACUTE CORONARY SYNDROME 33
993 ADENOCARCINOMA OF COLON 33
994 ALCOHOL USE 33
995 B-CELL LYMPHOMA 33
996 BOWEN^S DISEASE 33
997 BRAIN ABSCESS 33
998 CENTRAL NERVOUS SYSTEM LESION 33
999 COLON CANCER METASTATIC 33